Sung-Wook Nam

Prof. Dr. Sung-Wook Nam

Kyungpook National University, School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2022 in ACS Omega
Verified
Journal Article
Open access
Son Long HoSon Long Ho
Son Long Ho
HYHuan Yue
Huan Yue
TTTirusew Tegafaw
Tirusew Tegafaw
Mohammad Yaseen AhmadMohammad Yaseen Ahmad
Mohammad Yaseen Ahmad
SLShuwen Liu
Shuwen Liu
Gang Ho LeeGang Ho Lee
Gang Ho Lee
157Gd (natural abundance = 15.7%) has the highest thermal neutron capture cross section (σ) of 254,000 barns (1 barn = 10–28 m2) among stable (nonradioactive) isotopes in the periodic table. Another stable isotope, 155Gd (natural abundance = 14.8%), also has a high σ value of 60,700 barns. These σ values are higher than that of 10B (3840 barns, natural abundance = 19.9%), which is currently used as a neutron-absorbing isotope for boron neutron capture therapy agents. Energetic particles such as electrons and γ-rays emitted from Gd-isotopes after neutron beam absorption kill cancer cells by damaging DNAs inside cancer-cell nuclei without damaging normal cells if Gd-chemicals are positioned in cancer cells. To date, various Gd-chemicals such as commercial Gd-chelates used as magnetic resonance imaging contrast agents, modified Gd-chelates, nanocomposites containing Gd-chelates, fullerenes containing Gd, and solid-state Gd-nanoparticles have been investigated as gadolinium neutron capture therapy (GdNCT) agents. All GdNCT agents had exhibited cancer-cell killing effects, and the degree of the effects depended on the GdNCT agents used. This confirms that GdNCT is a promising cancer therapeutic technique. However, the commercial Gd-chelates were observed to be inadequate in clinical use because of their low accumulation in cancer cells due to their extracellular and noncancer targeting properties and rapid excretion. The other GdNCT agents exhibited higher accumulation in cancer cells, compared to Gd-chelates; consequently, they demonstrated higher cancer-cell killing effects. However, they still displayed limitations such as poor specificity to cancer cells. Therefore, continuous efforts should be made to synthesize GdNCT agents suitable in clinical applications. Herein, the principle of GdNCT, current status of GdNCT agents, and general design strategy for GdNCT agents in clinical use are discussed and reviewed.

5 September 2019 in MRS Bulletin
Verified
Journal Article
Closed access
PDF file
SKSangBum Kim
SangBum Kim
GBGeoffrey W. Burr
Geoffrey W. Burr
WKWanki Kim
Wanki Kim
SNSung-Wook Nam
Sung-Wook Nam

15 February 2018 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
BKBonhyeong Koo
Bonhyeong Koo
SBSegi Byun
Segi Byun
SNSung-Wook Nam
Sung-Wook Nam
SMSong‐Yi Moon
Song‐Yi Moon
SKSuncheul Kim
Suncheul Kim
BSByungha Shin
Byungha Shin

6 May 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
HLHyeji LEE
Hyeji LEE
KBKanghye Bae
Kanghye Bae
ABAhrum Baek
Ahrum Baek
EKEun-Bin Kwon
Eun-Bin Kwon
Yeoun-Hee KimYeoun-Hee Kim
Yeoun-Hee Kim
YCYongmin Chang
Yongmin Chang
The use of cancer-derived exosomes has been studied in several cancer types, but the cancer-targeting efficacy of glioma-derived exosomes has not been investigated in depth for malignant glioblastoma (GBM) cells. In this study, exosomes were derived from U87MG human glioblastoma cells, and selumetinib, a new anticancer drug, was loaded into the exosomes. We observed the tropism of GBM-derived exosomes in vitro and in vivo. We found that the tropism of GBM-derived exosomes is in contrast to the behavior of non-exosome-enveloped drugs and non-GBM-specific exosomes in vitro and in vivo in an animal GBM model. We found that the tropism exhibited by GBM-derived exosomes can be utilized to shuttle selumetinib, with no specific targeting moiety, to GBM tumor sites. Therefore, our findings indicated that GBM-derived exosomes loaded with selumetinib had a specific antitumor effect on U87MG cells and were non-toxic to normal brain cells. These exosomes offer improved therapeutic prospects for glioblastoma therapy.

15 June 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
TMTirusew Tegafaw Mengesha
Tirusew Tegafaw Mengesha
SLShuwen Liu
Shuwen Liu
Mohammad Yaseen AhmadMohammad Yaseen Ahmad
Mohammad Yaseen Ahmad
Abdullah Khamis Al SaidiAbdullah Khamis Al Saidi
Abdullah Khamis Al Saidi
DZDejun Zhao
Dejun Zhao
Gang Ho LeeGang Ho Lee
Gang Ho Lee
In recent decades, magnetic nanoparticles (MNPs) have attracted considerable research interest as versatile substances for various biomedical applications, particularly as contrast agents in magnetic resonance imaging (MRI). Depending on their composition and particle size, most MNPs are either paramagnetic or superparamagnetic. The unique, advanced magnetic properties of MNPs, such as appreciable paramagnetic or strong superparamagnetic moments at room temperature, along with their large surface area, easy surface functionalization, and the ability to offer stronger contrast enhancements in MRI, make them superior to molecular MRI contrast agents. As a result, MNPs are promising candidates for various diagnostic and therapeutic applications. They can function as either positive (T1) or negative (T2) MRI contrast agents, producing brighter or darker MR images, respectively. In addition, they can function as dual-modal T1 and T2 MRI contrast agents, producing either brighter or darker MR images, depending on the operational mode. It is essential that the MNPs are grafted with hydrophilic and biocompatible ligands to maintain their nontoxicity and colloidal stability in aqueous media. The colloidal stability of MNPs is critical in order to achieve a high-performance MRI function. Most of the MNP-based MRI contrast agents reported in the literature are still in the developmental stage. With continuous progress being made in the detailed scientific research on them, their use in clinical settings may be realized in the future. In this study, we present an overview of the recent developments in the various types of MNP-based MRI contrast agents and their in vivo applications.

31 October 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
TTTirusew Tegafaw
Tirusew Tegafaw
SLShuwen Liu
Shuwen Liu
MAMohammad Yaseen Ahmad
Mohammad Yaseen Ahmad
Abdullah Khamis Al SaidiAbdullah Khamis Al Saidi
Abdullah Khamis Al Saidi
DZDejun Zhao
Dejun Zhao
Gang Ho LeeGang Ho Lee
Gang Ho Lee
Nanodiamonds (ND) are chemically inert and stable owing to their sp3 covalent bonding structure, but their surface sp2 graphitic carbons can be easily homogenized with diverse functional groups via oxidation, reduction, hydrogenation, amination, and halogenation.